Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
Author:
Affiliation:
1. Medical Clinic II, J.W. Goethe University, Frankfurt, Germany
2. Private Praxis for Hematology/Oncology, Schifferstrasse, Frankfurt, Germany
3. Institute for Pathology, University Hospital, Erlangen, Nürnberg, Germany
Funder
funding
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1959319
Reference100 articles.
1. https://seer.cancer.gov/statfacts (cited 2021 Jun 13th).
2. https://ecis.jrc.ec.europa.eu (cited 2021 Jun 13th).
3. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
4. Non–Clear Cell Renal Cell Carcinomas: From Shadow to Light
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family;Molecular Biomedicine;2024-07-22
2. The role of immunotherapy in urological cancers;Archivio Italiano di Urologia e Andrologia;2024-05-30
3. The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma;Therapeutic Advances in Urology;2024-01
4. Nierenzellkarzinom;Therapie-Handbuch - Onkologie und Hämatologie;2024
5. The role of immunotherapy in non-clear cell renal cell carcinoma;Frontiers in Oncology;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3